Product Information
PROAIR RESPICLICK 90 MCG INHLR is a brand product labeled by Teva Respiratory, LLC, priced at $67.1795 per EA under NDC 59310058020. Its NADAC has been published 572 times since Oct 21, 2015.
FDA first approved this application on Mar 31, 2015.
The High Outlier badge above means this manufacturer's average price in the Albuterol Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
90 ug/1
Manufacturer
Teva Respiratory, LLCNDC
59310058020
Classification
Brand
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA205636FDA Approved
3/31/2015
On Market Since
4/23/2015
Pharmacological Classes
Price Statistics
The NADAC for PROAIR RESPICLICK 90 MCG INHLR has been published 572 times since Oct 21, 2015, and over the history we have for it it has risen 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $67.1795 per EA |
|---|---|
| All-time high | $67.2637 (May 13, 2026) |
| All-time low | $48.1617 (Oct 21, 2015) |
| 52-week high | $67.2637 |
| 52-week low | $65.3008 |
| Median price | $60.0944 |
| Average price | $59.6169 |
| Largest weekly change | +8.0% (Jan 9, 2019) |
| Weeks tracked | 572 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Albuterol Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Respiratory, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Albuterol Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROAIR RESPICLICK 90 MCG INHLR?
The current National Average Drug Acquisition Cost (NADAC) for PROAIR RESPICLICK 90 MCG INHLR, manufactured by Teva Respiratory, LLC, is $67.1795 per EA (NDC 59310058020), effective Sep 30, 2026.
How has the price of PROAIR RESPICLICK 90 MCG INHLR changed over time?
Over the history we have for it, the NADAC for PROAIR RESPICLICK 90 MCG INHLR has risen 39.5%. It has been tracked across 572 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for PROAIR RESPICLICK 90 MCG INHLR?
Since Oct 21, 2015, the NADAC for PROAIR RESPICLICK 90 MCG INHLR has ranged from a low of $48.1617 (Oct 21, 2015) to a high of $67.2637 (May 13, 2026), with a median of $60.0944 per EA.
Are there cheaper alternatives to PROAIR RESPICLICK 90 MCG INHLR?
No other NADAC-published product currently shares the active ingredient and strength of PROAIR RESPICLICK 90 MCG INHLR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROAIR RESPICLICK 90 MCG INHLR?
PROAIR RESPICLICK 90 MCG INHLR (NDC 59310058020) is labeled by Teva Respiratory, LLC, and CMS classifies it as a brand product.